UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000062853
Receipt number R000071955
Scientific Title Exploratory study on multifaceted health values of test food
Date of disclosure of the study information 2026/09/09
Last modified on 2026/09/09 10:34:14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Exploratory study on multifaceted health values of test food

Acronym

Exploratory study on multifaceted health values of test food

Scientific Title

Exploratory study on multifaceted health values of test food

Scientific Title:Acronym

Exploratory study on multifaceted health values of test food

Region

Japan


Condition

Condition

Healthy Adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effects of 4-week continuous intake of test food on skin moisture, bowel movements, fatigue, and diet-related urinary markers (such as indoxyl sulfate) in men and women aged 22 to 64 years old. The purpose is to identify optimal outcomes for subsequent confirmatory randomized controlled trials through this exploratory study and contribute to formulating market strategies that maximize the health value of test food.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

VAS (Visual Analog Scale) for skin dryness at baseline (before intake), and after 1, 2, 3, and 4 weeks of intake.

Key secondary outcomes

1. Skin moisture (measured by MS2-MO) at baseline, and after 1, 2, 3, and 4 weeks of intake.

2. VAS for fatigue (physical fatigue, mental fatigue, total fatigue) at baseline, and after 1, 2, 3, and 4 weeks of intake.

3. Constipation Assessment Scale (CAS) at baseline and after 4 weeks of intake.

4. Daily defecation questionnaire (stool volume, stool form) during the intake period.

5. Urinalysis (indoxyl sulfate) at baseline and after 4 weeks of intake.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Daily intake of 15 mL (once a day) of test food for 4 weeks (dilution with water etc. is permitted, no specified timing).

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

22 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

1) Persons who received a sufficient explanation of the purpose and contents of the study, applied voluntarily with sufficient understanding, and agreed to participate in the study with written consent.

2) Healthy Japanese male and female persons who are 22 years old or more and under 65 years old at the time of obtaining consent.

Key exclusion criteria

1) Persons who have chronic illness and receive medication, or have a serious disease history (except those judged by the supervising physician or principal investigator to have no issues).

2) Persons who have skin diseases (such as atopic dermatitis).

3) Persons who easily develop symptoms such as diarrhea or abdominal pain (weak gastrointestinal tract).

4) Persons who have food allergies to the test food.

5) Persons who are participating in other clinical studies.

6) Persons who are pregnant, may be pregnant, or are breastfeeding.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Makoto
Middle name
Last name Odawara

Organization

Kewpie Jyozo Co., Ltd.

Division name

Research Group

Zip code

182-0002

Address

Sengawa Kewport, 2-5-7, Sengawacho, Chofu-shi, Tokyo, JAPAN

TEL

03-5384-7670

Email

makoto_odawara@kewpie-jyozo.co.jp


Public contact

Name of contact person

1st name Yukiko
Middle name
Last name Kato

Organization

Kewpie Jyozo Co., Ltd.

Division name

Research Group

Zip code

306-0315

Address

Kotesashi 1800, Goka-machi, Sashima-gun, Ibaraki JAPAN

TEL

0280-84-2221

Homepage URL


Email

yukiko_kato@kewpie-jyozo.co.jp


Sponsor or person

Institute

Kewpie Jyozo Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Kewpie Jyozo Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Ethics Committee of Healthcare Systems Co., Ltd.

Address

1-14-18, Shirakane, Showa-ku, Nagoya, Aichi, JAPAN

Tel

03-6809-2722

Email

soumu@hc-sys.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 09 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 08 Month 24 Day

Date of IRB

2026 Year 08 Month 27 Day

Anticipated trial start date

2026 Year 09 Month 14 Day

Last follow-up date

2026 Year 11 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 09 Month 09 Day

Last modified on

2026 Year 09 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071955